![Jak Knowles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jak Knowles
Directeur/Membre du Conseil chez
Vesigen, Inc.
Profil
Jak Knowles was the founder of Affini-T Therapeutics, Inc., founded in 2021, serving as President, Chief Executive Officer & Director from 2021 to 2025.
Current jobs include Director at Vesigen, Inc. since 2020, Vice President-Medical & Scientific Affairs at CureDuchenne, and Venture Advisor at Agent Capital LLC.
Former jobs include Chief Executive Officer & Director at CytoSen Therapeutics, Inc., Director at NewLeaf Symbiotics, Inc. from 2018 to 2020, Director at CoverCress, Inc., Director at MyoTherix, Inc., Managing Director at CureDuchenne Ventures LLC from 2015 to 2017, Director at Triumvira Immunologics, Inc. in 2020, Director at Century Therapeutics, Inc. from 2019 to 2020, Director at Pyxis Oncology, Inc. from 2019 to 2020, Vice President at Bayer AG from 2018 to 2020, Equities Analyst at Citizens JMP Securities LLC in 2013, Equities Analyst at Burrill LLC, Associate at MPM BioImpact LLC, Principal at Oliver, Wyman & Co. LLC, Advisory at Bamboo Therapeutics, Inc. from 2015 to 2016, President at Exonics Therapeutics, Inc., Board Member at RASRx LLC from 2016 to 2017, Board Member at Trinds LLC from 2016 to 2017, and Chief Business Officer at Metagenomi Therapeutics, Inc. from 2020 to 2021.
Education includes a doctorate from Stanford University conferred in 2008 and an undergraduate degree from State University of New York at Binghamton conferred in 2001.
Postes actifs de Jak Knowles
| Sociétés | Poste | Début |
|---|---|---|
CureDuchenne
 CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Corporate Officer/Principal | - |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 22/07/2020 |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consultant / Advisor | - |
Anciens postes connus de Jak Knowles
| Sociétés | Poste | Fin |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Fondateur | 01/09/2025 |
| METAGENOMI THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2021 |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/11/2020 |
| CENTURY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2020 |
| PYXIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/11/2020 |
Formation de Jak Knowles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
JMP Securities LLC
 JMP Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
NewLeaf Symbiotics, Inc.
 NewLeaf Symbiotics, Inc. Chemicals: AgriculturalProcess Industries Develops and commercializes a family of beneficial bacteria | Process Industries |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Finance |
Oliver, Wyman & Co. LLC | |
CoverCress, Inc.
 CoverCress, Inc. Information Technology ServicesTechnology Services Develops seed technology for oilseed producer and processing | Technology Services |
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Health Technology |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
CytoSen Therapeutics, Inc.
 CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanoparticle-based technology and therapeutics | Commercial Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
RASRx LLC
 RASRx LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development laboratories services | Commercial Services |
Trinds LLC
 Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Commercial Services |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
